Same Indication

Ipilimumab vs Methylprednisolone

Ipilimumab vs Methylprednisolone: Overview

This comparison examines the pharmacological differences between Ipilimumab and Methylprednisolone.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Methylprednisolone: Intermediate-acting synthetic glucocorticoid.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days; Methylprednisolone β€” 18-36 hours.

Chemical Properties

Molecular Formula: Methylprednisolone β€” C22H30O5.

Molecular Weight: Methylprednisolone β€” 374.4710 g/mol.

Type: Ipilimumab β€” Antibody; Methylprednisolone β€” Small molecule.